DFTX
Definium Therapeutics, Inc.
NASDAQ: DFTX · HEALTHCARE · BIOTECHNOLOGY
$21.40
-2.95% today
Updated 2026-05-11
Market cap
$2.40B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.50
Dividend yield
—
52W range
$6 – $26
Volume
1.9M
Definium Therapeutics, Inc. (DFTX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | $5500.00 | $6681.00 | $6683.00 | — | — | — | $3.16M | $527000.00 | — |
| Gross profit | — | — | $-5500.00 | $-6681.00 | $-6683.00 | — | — | — | $-3.16M | $-527000.00 | — |
| Gross margin | — | — | — | — | — | — | — | — | — | — | — |
| R&D | — | — | — | — | — | $18.63M | $34.79M | $36.17M | $48.96M | $65.30M | $117.67M |
| SG&A | — | — | — | — | — | $14.40M | $59.06M | $30.16M | $41.74M | $38.62M | $48.64M |
| Operating income | $-94550.00 | $-111250.00 | $-1.24M | $-861940.00 | $-468180.00 | $-33.03M | $-93.85M | $-66.33M | $-93.87M | $-103.92M | $-166.31M |
| Operating margin | — | — | — | — | — | — | — | — | — | — | — |
| EBITDA | $-92656.00 | $-111250.00 | $-1.51M | $-851262.00 | $-1.11M | $-33.57M | $-91.24M | $-63.15M | $-92.57M | $-105.87M | $-178.31M |
| EBITDA margin | — | — | — | — | — | — | — | — | — | — | — |
| EBIT | $-92656.00 | — | $-1.51M | $-857943.00 | $-1.12M | $-33.77M | $-93.85M | $-66.33M | $-95.73M | $-106.40M | — |
| Interest expense | — | — | — | — | — | $164000.00 | $359000.00 | $1.50M | $920000.00 | $2.28M | $5.48M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-92656.00 | $-179900.00 | $-1.23M | $-857944.00 | $-1.12M | $-34.10M | $-93.04M | $-56.80M | $-95.73M | $-108.68M | $-183.79M |
| Net income growth (YoY) | — | -94.2% | -581.9% | +30.1% | -30.1% | -2956.2% | -172.8% | +39.0% | -68.6% | -13.5% | -69.1% |
| Profit margin | — | — | — | — | — | — | — | — | — | — | — |